Medtechs made it out of Q2 with minimal impact from delta. That could change in Q3.

Medtechs made it out of Q2 with minimal impact from delta. That could change in Q3.

Submitted by admin on August 27, 2021 - 10:49am
Source: 
Medtech Dive
News Tags: 
devices
Medtech
pandemic
elective surgery
COVID-19
Delta COVID-19 variant
Headline: 
Medtechs made it out of Q2 with minimal impact from delta. That could change in Q3.
snippet: 

Procedure-dependent companies reported little to no impact from the variant in the second quarter. But rising COVID-19 cases and elective shutdowns pose a risk in the second half of the year.

Do Not Allow Advertisers to Use My Personal information